Characteristic | Episodic migraine (NCT02456740) STRIVE | Episodic migraine (NCT02483585) ARISE | Chronic migraine (NCT02066415) | |||||
---|---|---|---|---|---|---|---|---|
Placebo | Erenumab 70 mg | Erenumab 140 mg | Placebo | Erenumab 70 mg | Placebo | Erenumab 70 mg | Erenumab 140 mg | |
Number of patients | 319 | 317 | 319 | 291 | 286 | 286 | 191 | 190 |
Mean age, years (SD) | 41.3 (11.2) | 41.1 (11.3) | 40.4 (11.1) | 42.2 (11.5) | 42.3 (11.4) | 42.1 (11.3) | 41.4 (11.3) | 42.9 (11.1) |
Sex, n (%) | ||||||||
 Male | 45 (14.1) | 48 (15.2) | 47 (14.7) | 44 (15.1) | 41 (14.3) | 60 (21.0) | 25 (13.1) | 30 (15.8) |
 Female | 274 (85.9) | 269 (84.8) | 272 (85.3) | 247 (84.9) | 245 (85.7) | 226 (79.0) | 166 (86.9) | 160 (84.2) |
Race, n (%) | ||||||||
 White | 276 (86.8) | 280 (88.6) | 293 (91.9) | 259 (89.0) | 259 (90.6) | 268 (93.7) | 176 (92.1) | 184 (96.8) |
 Black | 24 (7.5) | 24 (7.6) | 18 (5.6) | 27 (9.3) | 24 (8.4) | 11 (3.8) | 10 (5.2) | 6 (3.2) |
 Other | 18 (5.7) | 12 (3.8) | 8 (2.5) | 5 (1.7) | 3 (1.0) | 7 (2.5) | 5 (2.6) | 0 (0.0) |
MMD | 8.2 ± 2.5 | 8.3 ± 2.5 | 8.3 ± 2.5 | 8.4 ± 2.6 | 8.1 ± 2.7 | 18.2 ± 4.7 | 17.9 ± 4.4 | 17.8 ± 4.7 |